Literature DB >> 35488930

Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice.

Grace M Lloyd1,2, Zachary A Sorrentino1,2, Stephan Quintin1,2, Kimberly-Marie M Gorion1,2, Brach M Bell1,2, Giavanna Paterno1,2, Brooke Long2, Stefan Prokop2,3,4, Benoit I Giasson5,6,7.   

Abstract

α-synuclein (αSyn) is an intrinsically disordered protein which can undergo structural transformations, resulting in the formation of stable, insoluble fibrils. αSyn amyloid-type nucleation can be induced by misfolded 'seeds' serving as a conformational template, tantamount to the prion-like mechanism. Accumulation of αSyn inclusions is a key feature of dementia with Lewy bodies (DLB) and multiple system atrophy (MSA), and are found as additional pathology in Alzheimer's disease (AD) such as AD with amygdala predominant Lewy bodies (AD/ALB). While these disorders accumulate the same pathological protein, they exhibit heterogeneity in clinical and histological features; however, the mechanism(s) underlying this variability remains elusive. Accruing data from human autopsy studies, animal inoculation modeling, and in vitro characterization experiments, have lent credence to the hypothesis that conformational polymorphism of the αSyn amyloid-type fibril structure results in distinct "strains" with categorical infectivity traits. Herein, we directly compare the seeding abilities and outcome of human brain lysates from these diseases, as well as recombinant preformed human αSyn fibrils by the intracerebral inoculation of transgenic mice overexpressing either human wild-type αSyn or human αSyn with the familial A53T mutation. Our study has revealed that the initiating inoculum heavily dictates the phenotypic and pathological course of disease. Interestingly, we have also established relevant host-dependent distinctions between propagation profiles, including burden and spread of inclusion pathology throughout the neuroaxis, as well as severity of neurological symptoms. These findings provide compelling evidence supporting the hypothesis that diverse prion-type conformers may explain the variability seen in synucleinopathies.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease with amygdala predominant Lewy bodies; Amyloid; Dementia with Lewy bodies; Multiple system atrophy; Prion; Strains; Synucleinopathy; α-synuclein

Mesh:

Substances:

Year:  2022        PMID: 35488930      PMCID: PMC9199436          DOI: 10.1007/s00401-022-02425-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   15.887


  89 in total

Review 1.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice.

Authors:  Nicola J Rutherford; Jess-Karan S Dhillon; Cara J Riffe; Jasie K Howard; Mieu Brooks; Benoit I Giasson
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

3.  Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid.

Authors:  K Xu; A T Malouf; A Messing; J Silver
Journal:  Glia       Date:  1999-02-15       Impact factor: 7.452

4.  Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice.

Authors:  Amanda N Sacino; Mieu Brooks; Michael A Thomas; Alex B McKinney; Sooyeon Lee; Robert W Regenhardt; Nicholas H McGarvey; Jacob I Ayers; Lucia Notterpek; David R Borchelt; Todd E Golde; Benoit I Giasson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

5.  A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114.

Authors:  Adam S Crystal; Benoit I Giasson; Alexander Crowe; Mei-Ping Kung; Zhi-Ping Zhuang; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

6.  Strain diversity in neurodegenerative disease: an argument for a personalized medicine approach to diagnosis and treatment.

Authors:  Amanda L Woerman
Journal:  Acta Neuropathol       Date:  2021-04-23       Impact factor: 17.088

Review 7.  Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.

Authors:  Toshiki Uchihara; Benoit I Giasson
Journal:  Acta Neuropathol       Date:  2015-10-07       Impact factor: 17.088

Review 8.  Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.

Authors:  Ronald Melki
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

9.  Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy.

Authors:  Ethan W Hass; Zachary A Sorrentino; Grace M Lloyd; Nikolaus R McFarland; Stefan Prokop; Benoit I Giasson
Journal:  Acta Neuropathol Commun       Date:  2021-05-03       Impact factor: 7.801

10.  α-Synuclein strains target distinct brain regions and cell types.

Authors:  Angus Lau; Raphaella W L So; Heather H C Lau; Jason C Sang; Alejandro Ruiz-Riquelme; Shelaine C Fleck; Erica Stuart; Sindhu Menon; Naomi P Visanji; Georg Meisl; Rania Faidi; Maria M Marano; Cian Schmitt-Ulms; Zhilan Wang; Paul E Fraser; Anurag Tandon; Bradley T Hyman; Holger Wille; Martin Ingelsson; David Klenerman; Joel C Watts
Journal:  Nat Neurosci       Date:  2019-12-02       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.